EA201791978A1 - Биомаркеры преэклампсии - Google Patents

Биомаркеры преэклампсии

Info

Publication number
EA201791978A1
EA201791978A1 EA201791978A EA201791978A EA201791978A1 EA 201791978 A1 EA201791978 A1 EA 201791978A1 EA 201791978 A EA201791978 A EA 201791978A EA 201791978 A EA201791978 A EA 201791978A EA 201791978 A1 EA201791978 A1 EA 201791978A1
Authority
EA
Eurasian Patent Office
Prior art keywords
preeclampsia
preeclampsia biomarkers
biomarkers
hemopexin
microglobulin
Prior art date
Application number
EA201791978A
Other languages
English (en)
Inventor
Стефан Ханссон
Бо Акерстром
Магнус Горан Грам
Original Assignee
А1М Фарма Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by А1М Фарма Аб filed Critical А1М Фарма Аб
Publication of EA201791978A1 publication Critical patent/EA201791978A1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4713—Plasma globulins, lactoglobulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Настоящее изобретение относится к применению гемопексина, свободного не связанного с клетками гемоглобина и альфа-1-микроглобулина в качестве маркеров преэклампсии.
EA201791978A 2015-03-16 2016-03-16 Биомаркеры преэклампсии EA201791978A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201570146 2015-03-16
DKPA201570794 2015-12-03
PCT/EP2016/055619 WO2016146647A1 (en) 2015-03-16 2016-03-16 Biomarkers for preeclampsia

Publications (1)

Publication Number Publication Date
EA201791978A1 true EA201791978A1 (ru) 2018-01-31

Family

ID=55586291

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791978A EA201791978A1 (ru) 2015-03-16 2016-03-16 Биомаркеры преэклампсии

Country Status (14)

Country Link
US (1) US20180074070A1 (ru)
EP (1) EP3271727A1 (ru)
JP (1) JP2016173366A (ru)
KR (1) KR20170125975A (ru)
CN (1) CN107430134A (ru)
AU (1) AU2016232309A1 (ru)
BR (1) BR112017018436A2 (ru)
CA (1) CA2977458A1 (ru)
EA (1) EA201791978A1 (ru)
MX (1) MX2017011198A (ru)
SG (1) SG11201706736RA (ru)
TW (1) TW201702383A (ru)
WO (1) WO2016146647A1 (ru)
ZA (1) ZA201705532B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108776226B (zh) * 2018-04-08 2021-03-19 邓成 晚发型子痫前期快速筛查用试纸和试剂盒
JP2021528476A (ja) * 2018-06-28 2021-10-21 サルアクア ダイアグノスティックス， インコーポレイテッド ハプトグロビン関連タンパク質と関係する組成物および方法
CN109867717A (zh) * 2019-04-01 2019-06-11 山西瑞亚力生物技术有限公司 一种血浆中α1微球蛋白的提取方法
WO2022149410A1 (ja) * 2021-01-05 2022-07-14 公立大学法人横浜市立大学 妊孕性を判定するためのバイオマーカー及びそれを用いた判定方法
CN113092777B (zh) * 2021-03-26 2023-11-14 泰达国际心血管病医院 孕早期进行重症子痫前期患者筛查的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0808340A2 (pt) 2007-02-12 2017-05-30 Akerström Bo uso de hemoglobina fetal, hemoglobina fetal, métodos para diagnosticar ou auxiliar a diagnosticar pré-eclampsia, para monitorar a progressão ou regressão de pré-eclampsia, para avaliar a eficácia de um tratamento de pré-eclampsia,para prevenir ou tratar pré-eclampsia, e para prognosticar pré-eclampsia, kit de ensaio, e, uso de uma ou mais substâncias selecionadas dentre agentes de ligação de hemoglobina, agentes de ligação de heme, agentes de degradação de heme e/ou agentes de ligação de ferro
KR20130012023A (ko) 2010-03-24 2013-01-30 프리루미나 다이어그노스틱스 아베 임신중독증에 대한 초기 단계 마커로서 ｈｂｆ 및 ａ１ｍ
US20150099655A1 (en) * 2012-05-08 2015-04-09 The Board Of Trustees Of The Leland Stanford Junior University Methods and Compositions for Providing a Preeclampsia Assessment
CA2907224C (en) * 2013-03-15 2023-10-17 Sera Prognostics, Inc. Biomarkers and methods for predicting preeclampsia

Also Published As

Publication number Publication date
SG11201706736RA (en) 2017-09-28
TW201702383A (zh) 2017-01-16
MX2017011198A (es) 2018-02-19
JP2016173366A (ja) 2016-09-29
EP3271727A1 (en) 2018-01-24
US20180074070A1 (en) 2018-03-15
ZA201705532B (en) 2020-01-29
AU2016232309A1 (en) 2017-09-28
CN107430134A (zh) 2017-12-01
BR112017018436A2 (pt) 2018-04-17
CA2977458A1 (en) 2016-09-22
WO2016146647A1 (en) 2016-09-22
KR20170125975A (ko) 2017-11-15

Similar Documents

Publication Publication Date Title
MX2020009461A (es) Anticuerpos anti-proteína que contiene dominio de inmunologlubina rfig elacionado con el receptor de poliovirus (pvrig) y métodos de uso.
MD3827845T2 (ro) Formulări subcutanate de anticorpi anti-CD38 și utilizări ale acestora
EA201891338A1 (ru) Композиции и способы для иммуноонкологии
EA201592074A1 (ru) Композиции и способы изменения сигнальной системы вторичного мессенджера
PH12016501763A1 (en) Multispecific antibodies
EA201792613A1 (ru) Модуляторы cot и способы их применения
EA202092435A3 (ru) Моноклональные антитела против bcma
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
TWD180147S (zh) 淨水器
EA201692425A1 (ru) Модифицированные биополимеры и способы их получения и использования
ZA201902141B (en) Acid-alpha glucosidase variants and uses thereof
EA201691610A8 (ru) Анти-jagged1 антитела и способы применения
EA201791424A1 (ru) Получение белка
CL2017002238A1 (es) Método de tratamiento con tradipitant
PH12019500376A1 (en) Acid-alpha glucosidase variants and uses thereof
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
EA201791978A1 (ru) Биомаркеры преэклампсии
EA201790505A1 (ru) Соединение, нацеленое на ил-23а и фно-альфа, и его применение
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
EA201792372A1 (ru) Композиции и способы для активного наблюдения за раком предстательной железы
TWD174041S (zh) 手錶
TR201902875T4 (tr) Plk-4 inhibitörünün tuz ve kristal formları.
TWD180369S (zh) 無儲水桶式逆滲透淨水器
EA202091497A2 (ru) Генетические локусы, связанные с повышенной фертильностью у маиса
BR112016027455A2 (pt) moduladores ppar